In this regard, an immunogen like PLVF with a clear potency for inducing an OAg-specific IgA response on the gastrointestinal mucosa (especially in the oral cavity and colon) should be considered the most promising vaccine candidate for field protection against shigellosis. The gene discussed is CD79A; the disease is shigellosis.